
Cambridge-based genetics research firm Horizon Discovery has appointed Dr David Smoller to be an executive director on its board. Smoller …
MHRA approves Romvimza for tenosynovial giant cell tumour
Panthera opens clinical trial site at Keele University
Santen joins inaugural Global Summit for Eye Health as partner

